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DOTS in primary care units 
in the city of Rio de Janeiro, 
Southeastern Brazil
Implementação e resultados do 
DOTS em unidades básicas de saúde 
na cidade do Rio de Janeiro
ABSTRACT
OBJECTIVE: To describe the implantation and the effects of directly-observed 
treatment short course (DOTS) in primary health care units.
METHODS: Interviews were held with the staff of nine municipal health care 
units (MHU) that provided DOTS in Rio de Janeiro City, Southeastern Brazil, 
in 2004-2005. A dataset with records of all tuberculosis treatments beginning 
in 2004 in all municipal health care units was collected. Bivariate analyses and 
a multinomial model were applied to identify associations between treatment 
outcomes and demographic and treatment process variables, including being 
in DOTS or self-administered therapy (SAT).
RESULTS: From 4,598 tuberculosis cases treated in public health units 
administrated by the municipality, 1,118 (24.3%) were with DOTS and 3,480 
(75.7%) with SAT. The odds of DOTS were higher among patients with age 
under 50 years, tuberculosis relapse and prior history of default or treatment 
failure. The odds of death were 52.0% higher among patients on DOTS as 
compared to SAT. DOTS modality including community health workers 
(CHWs) showed the highest treatment success rate. A reduction of 21.0% 
was observed in the odds of default (vs. cure) among patients on DOTS as 
compared to patients on SAT, and a reduction of 64.0% among patients on 
DOTS with CHWs as compared to those without CHWs.
CONCLUSIONS: Patients with a “low compliance profi le” were more likely 
to be included in DOTS. This strategy improves the quality of care provided 
to tuberculosis patients, although the proposed goals were not achieved.
DESCRIPTORS: Tuberculosis, prevention & control. Antitubercular 
Agents, supply & distribution. Medication Adherence. Patient Dropouts. 
Treatment Outcome. Health Services.
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According to the World Health Organization (WHO), 
Brazil ranks 18th among 22 countries in tuberculosis 
(TB) cases accounting for 80.0% of all cases world-
wide. Data from Brazil’s National Notifi able Diseases 
Database (SINAN) for the year 2004 show a national 
reporting rate of 45.3 cases per 100,000 inhabitants.
Given the relevance of TB in Brazil, in 1998, the 
Brazilian Ministry of Health launched the National Plan 
to Fight Tuberculosis, which proposed the implementa-
tion of the Directly Observed Treatment Short-Course 
(DOTS) Strategy, tuberculosis control programs (TCP) 
in 100.0% of the country’s municipalities, adequate 
treatment of 100.0% of the diagnosed cases, cure of 
at least 85.0% of these cases, and a default rate of 
less than 5.0%. Brazil endorsed the fi rst WHO Global 
DOTS Expansion Plan in 2000 and TB was declared 
a national priority in 2004. An action plan was drafted 
for 2004–2007, defi ning the 315 municipalities with 
70.0% of the country’s TB cases as the priority for 
RESUMO
OBJETIVO: Descrever a implantação e os efeitos do directly-observed 
treatment short course (DOTS) em centros municipais de saúde.
MÉTODOS: Foram realizadas entrevistas com profi ssionais dos nove centros 
municipais de saúde que ofereciam DOTS no Rio de Janeiro, RJ, em 2004-2005. 
Foram coletados os dados de todos os centros municipais de saúde da cidade 
sobre os tratamentos de tuberculose iniciados em 2004. Análises bivariadas 
e modelo multinomial foram aplicados para identifi car associações entre 
resultados do tratamento e variáveis demográfi cas e relativas ao processo de 
tratamento, incluindo estar em DOTS ou terapia auto-administrada (SAT).
RESULTADOS: Dos 4.598 casos de tuberculose tratados, 1.118 (24,3%) 
utilizaram DOTS e 3.480 (75,7%), SAT. As chances de uso de DOTS foram 
maiores entre pacientes com menos de 50 anos, recidiva de tuberculose, 
história prévia de abandono ou falência de tratamento. As chances de morte 
foram 52,0% maiores entre pacientes em DOTS comparados àqueles em 
SAT. A modalidade de tratamento com maior sucesso foi DOTS com agentes 
comunitários de saúde. Foi observada redução de 21,0% na razão de chances 
de abandono (vs. cura) entre pacientes em DOTS, comparados a pacientes em 
SAT, e redução de 64,0% entre pacientes em DOTS com ACS, comparados 
àqueles sem.
CONCLUSÕES: Pacientes com perfi l de menor adesão ao tratamento tenderam 
a ser incluídos em DOTS. Essa estratégia melhora a qualidade da atenção 
provida a pacientes com tuberculose, ainda que metas propostas não tenham 
sido atingidas.
DESCRITORES: Tuberculose, prevenção & controle. Antituberculosos, 
provisão & distribuição. Adesão à Medicação. Pacientes Desistentes do 
Tratamento. Resultado de Tratamento. Serviços de Saúde.
INTRODUCTION
a Secretaria de Estado de Saúde do Rio de Janeiro. Boletim Informativo do Programa de Controle da Tuberculose do Estado do Rio de Janeiro. 
Rio de Janeiro; 2005.
strengthening disease control measures and expanding 
supervised TB treatment to include 100.0% of health 
units in these municipalities.
The state of Rio de Janeiro, Southeastern Brazil, has 
the highest annual TB incidence rate in Brazil. In 2004, 
15,755 cases of TB were reported in the state, accounting 
for approximately 15.0% of all cases in Brazil. Rio de 
Janeiro has also the highest TB mortality rate in Brazil, 
i.e., 6.0 per 100,000 inhabitants in 2004, nearly twice the 
national rate.a It also accounted for 42.0% of multidrug-
resistant tuberculosis (MDR-TB) cases in the Southeast 
in 2000–2003, the Brazilian region with the highest 
proportion of cases in the country (66.4%).3 Cure rate 
was 68.2% and default rate was 16.3% in 2004. Of all 
cases reported in the state of Rio de Janeiro, 54.0% lived 
in the city of Rio de Janeiro.
According to the literature,12,16,18,20,24,25 DOTS with 
enablers showed a treatment completion rate of 86.0 
42 DOTS in Rio de Janeiro City Ferreira V et al
b Ministério da Saúde. Secretaria de Políticas de Saúde. Departamento de Atenção Básica. Manual técnico para o controle da tuberculose. 
Brasília, DF; 2002.
to 96.5% and a relapse rate of 0.0 to 11.5%. Without 
treatment regularity, enablers and incentives, treat-
ment completion rate ranged from 85.0% to 87.6% 
and relapse rate from 0.8% to 4.9%. In addition, non-
supervised strategies were associated to treatment 
completion rates ranging from 41.9% to 82.0% and 
relapse rates from 2.1% to 4.5%. DOTS was more 
cost-effective than self-administered treatment (SAT), 
particularly when epidemiological indicators point to 
high default, relapse, multi-resistant TB, and mortality 
rates.2,3,5,6,8,9,13,21
Castelo Filho et al3 highlight that the impact of the 
implementation of DOTS strategy under different condi-
tions and at various levels on TB treatment outcomes 
is due more to the set of organizational measures as a 
whole than direct observation of dose-taking. Supervised 
treatment should be applied with creative recommenda-
tions adjusted to Brazilian conditions, contemplating the 
country’s diversity, especially in large cities, which have 
more than 80.0% of all TB cases in Brazil.
The various strategies to expand the National 
Tuberculosis Control Plan to all Brazilian municipali-
ties also include the expansion and consolidation of 
the Brazilian Ministry of Health Community Health 
Workers (CHW) Program and the Family Health 
Program (FHP) in partnership with local governments.b 
FHP coverage in the state of Rio de Janeiro was 24.0% 
in 2004 and 8.0% in the metropolitan area I (accounting 
for 76.0% of TB cases in the state).a
DOTS implantation in the city of Rio de Janeiro began 
with a pilot project in 1999, funded by the Brazilian 
Ministry of Health with resources from the Tuberculosis 
Emergency Plan. Expansion to other locations was 
based on epidemiological, operational, and geographic 
criteria. The local Tuberculosis Control Program (TCP) 
contacted selected primary care services and held meet-
ings with their managers and providers. Informative 
material was developed and distributed to TCP teams 
and patients. DOTS trainings were offered to TCP 
teams, and material focused on treatment data collection 
was developed and distributed to health units. Spaces 
were rebuilt or adapted, and equipment, supplies and 
human resources were provided to the units.
Nine units of 32 municipal health centers providing 
TCP offered DOTS to their patients in 2004–2005. 
The DOTS strategy was not exclusively provided and 
patients could choose SAT.
DOTS teams in municipal health centers consisted 
mainly of a physician, a nurse and a nursing assistant. 
Of the nine municipal health centers with DOTS, one 
included a CHW in the team selected among young 
residents of Rocinha slum, and trained on TB, DOTS, 
and FHP. Following the Brazilian guidelines for TB 
treatment with only three drugs, patients were treated 
with a directly observed six-month regimen consisting 
of daily rifampin, isoniazid and pyrazinamide (RHZ) 
for two months, followed by four months of twice-
weekly rifampin and isoniazid (2RHZ/4R2H2). The 
coverage of DOTS in the city of Rio de Janeiro was 
24.3% in 2004.
The objective of the present study was to describe 
DOTS implementation and its impact on primary care 
services.
METHODS
Descriptive study with managers and TCP health 
providers carried out in primary care units with DOTS 
in the city of Rio de Janeiro. The study analyzed epide-
miological secondary data of all primary care units 
providing TCP.
The heads of the local TCP were interviewed and 
general information about DOTS implementation in the 
city and the nine health units already providing DOTS 
were collected in August 2005.
Directors and health providers in charge of DOTS 
in the nine health units were also interviewed from 
April to July 2006 to characterize their structure and 
strategies. DOTS was implanted not as an exclusive 
treatment modality, but as an alternative to SAT. 
DOTS was exclusively offered in the community and 
monitored by CHWs.
Evaluation of treatment outcomes was based on TB 
records from all primary care units with or without 
DOTS. The original dataset consisted of 5,984 records 
from the Tuberculosis Case and Treatment Registry 
Database submitted to the local TBP including all 
treatments starting from January 1 to December 31, 
2004. TB treatment provided in hospitals and mater-
nity wards (1,066 cases) were excluded and only 
treatment provided in primary care units managed by 
the Health Department of the City of Rio de Janeiro 
were included. Entries with “change of diagnosis” (71 
cases) or “transfer” (223 cases) were also excluded 
as well as those that did not include data specifi cally 
reporting DOTS (26 cases). There were a total 4,598 
records of TB treatments, which were evaluated as to 
the adequacy of the treatment regimen and observed 
outcome, considering mainly the roles played by DOTS 
and CHWs. These roles were identifi ed by a variable 
created by the local TCP and added to the Tuberculosis 
Case and Treatment Registry Database.
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The independent variables were indicators of receiving 
DOTS and its specifi c strategy of involving CHWs. 
Other independent variables included: (1) treatment 
adequacy/inadequacy (according to the Brazilian 
Ministry of Health treatment guidelines); (2) treatment 
outcome (both confi rmed and unconfi rmed cures were 
classifi ed as cures); (3) treatments type (initial, post-
relapse, post-default, and post-failure); and (4) form of 
TB and information on HIV infection.
Explorations were developed to identify patterns for 
patient inclusion in DOTS, as well as differences DOTS 
made in health care process.
Bivariate analyses were performed to assess any asso-
ciations between treatment outcomes (cure, default, 
death, failure, and unknown) and patient and process-
of-care characteristics. A multinomial model was 
used to identify the independent effects of the target 
explanatory variables on outcomes compared to cure. 
For the statistical analyses SUDAAM software version 
SAS® was used to deal with clustering of records in a 
single health unit.
The study was approved by the Research Ethics 
Committee of the Fundação Oswaldo Cruz National 
School of Public Health (ENSP-FIOCRUZ). All inter-
views were conducted after participants signed a free 
informed consent form.
RESULTS
Three of the nine primary care units providing DOTS 
had implemented it less than three years previous to 
the study and six of them more than three years before. 
Three units were open for up to 49 hours a week, were 
staffed with fewer than 100 people, and provided up to 
8,000 medical consultations per month. Five units were 
open from 50 to 54 hours a week, had from 101 to 200 
staff people, and provided 8,001 to 16,000 consultations 
per month. One unit was open 70 hours a week, had 
more than 200 staff people, and provided more than 
16,000 consultations per month.
Six units reported diffi culties in implementing DOTS 
mostly due to lack of personnel to provide home visits. 
Eight units identifi ed issues regarding home visits due 
to lack of personnel and a vehicle and violence. When 
DOTS patients missed their appointments, they were 
mostly often contacted by telephone calls, followed by 
home visits and certifi ed letters.
The proportion of patients participating in DOTS in the 
nine local health units ranged from 25.1% to 100.0%. 
Two units reached the treatment success target set by 
the Brazilian Ministry of Health (86.3% and 88.1%, 
respectively). The best result was seen at the unit 
involving CHWs, which is the community reference 
service for DOTS program. As for default, the 5.0% 
target was not reached by any of the local health units, 
and only three showed rates below 10.0%.
Of the 4,598 TB treatments assessed in all 32 local health 
units participating in TCP, 1,118 (24.3%) were super-
vised (815 DOTS alone and 303 DOTS with CHWs) and 
3,480 (75.7%) were self-administered (SAT).
The assessment of factors associated with DOTS or 
SAT showed that the former was more often provided 
to patients younger than 50, TB relapse and prior 
history of default or treatment failure. Statistically 
signifi cant negative relationships were found between 
DOTS and unknown sputum smear result, inadequate 
treatment regimen, and positive or unknown HIV 
status. High rates of unknown sputum smear results 
(overall, 31.6%; DOTS, 25.4%; SAT, 33.6%) and HIV 
status (overall, 62.7%; DOTS, 44.0%; SAT, 68.7%) 
were major indicators of TB care.
Table 1 shows bivariate analyses of TB treatment 
outcomes and patient characteristics, as well as health 
care indicators. Of all treatments studied, 48 (1.0%) 
lacked information on reason for discharge.
Table 2 shows the results of the multinomial model 
designed to identifying factors associated with TB 
treatment outcomes.
Patients who defaulted treatment were more likely to 
be younger (less than 30 years old; reference category: 
30–49 years old), male, have positive or unknown 
sputum smear, pulmonary TB, positive or unknown 
HIV status, and receive treatment for relapse or previous 
default. Older patients (50–59 and ≥60 years old; refer-
ence category: 30–49 years old) with normal X-ray, 
receiving DOTS alone, and DOTS plus CHWs were 
less likely to default treatment. There was found a 21.0% 
reduction in the likelihood of default among patients on 
DOTS compared to those on SAT and a 64.0% reduction 
among those patients monitored by CHWs.
Positive associations were found between death and age, 
male gender, previous default, and positive or unknown 
HIV status. Death rates were also 52.0% higher among 
patients on DOTS compared to SAT. Death (versus cure) 
rates were lower among younger patients and those with 
positive sputum smear. Follow-up with CHWs also 
showed a statistically borderline protective effect.
Treatment failure was higher among older patients 
(50–59 and ≥60 years), those with positive sputum 
smear, in treatment due to relapse or previous default 
or failure and those on DOTS. Failure rates were lower 
among patients with normal chest X-ray.
Unknown outcome was more commonly seen among 
patients with previous failure, inadequate treatment 
regimen, and positive HIV status, and less often seen 
among patients with normal X-ray and those monitored 
by CHWs.
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Table 1. Bivariate analyses comparing reason for patient discharge and potential explanatory variables. City of Rio de Janeiro, 
Southeastern Brazil, 2004.
Variable n %
Cure
(n=3,488)
Default
(n=828)
Death
(n=181)
Failure 
(n=53)
Unknown
(n=48) χ2
(p-value)
n % n % n % n % n %
Age (years) <0.0001
<30 1,577 34.3 1,201 34.4 339 40.9 14 7.7 15 28.3 8 16.7
30 to 49 1,901 41.3 1,429 41.0 368 44.4 63 34.8 18 34.0 23 47.9
50 to 59 584 12.7 465 13.3 59 7.1 42 23.2 11 20.7 7 14.6
≥60 515 11.2 381 10.9 56 6.8 60 33.2 9 17.0 9 18.7
Unknown 21 0.5 12 0.4 6 0.7 2 1.1 0 0.0 1 2.1
Gender <0.0001
Male 2,955 64.3 2,143 61.4 599 72.3 139 76.8 39 73.6 35 72.9
Female 1643 35.7 1,345 38.6 229 27.7 42 23.2 14 26.4 13 27.1
Sputum smear <0.0001
Positive 2,331 50.7 1,804 51.7 400 48.3 64 35.3 42 79.3 21 43.7
Negative 815 17.7 645 18.5 113 13.7 45 24.9 5 9.4 7 14.6
Unknown 1,452 31.6 1,039 29.8 315 38.0 72 39.8 6 11.3 20 41.7
X-ray <0.0001
Abnormal 4,210 91.5 3,190 91.5 762 92.0 164 90.6 49 92.5 45 93.8
Normal 113 2.5 102 2.9 7 0.9 4 2.2 0 0.0 0 0.0
Unknown 275 6.0 196 5.6 59 7.1 13 7.2 4 7.5 3 6.2
Pulmonary form <0.0001
Yes 4,015 87.3 3,005 86.1 764 92.3 154 85.1 52 98.1 40 83.3
No 583 12.7 483 13.9 64 7.7 27 14.9 1 1.9 8 16.7
Type of treatment <0.0001
Initial 3,937 85.6 3,095 88.7 630 76.1 143 79.0 32 60.4 37 77.1
Relapse 352 7.7 259 7.4 62 7.5 19 10.5 9 17.0 3 6.3
Previous default 282 6.1 118 3.4 134 16.2 17 9.4 8 15.1 5 10.4
Previous failure 29 0.6 16 0.5 2 0.2 2 1.1 4 7.5 3 6.3
Treatment regimen <0.0001
Inadequate 202 4.4 132 3.8 52 6.3 9 5.0 3 5.7 6 12.5
Adequate 4,396 95.6 3,356 96.2 776 93.7 172 95.0 50 94.3 42 87.5
HIV test <0.0001
Positive 316 6.9 201 5.8 72 8.7 30 16.6 3 5.6 10 20.8
Negative 1,399 30.4 1,223 35.0 120 14.5 18 9.9 25 47.2 13 27.1
Unknown 2,883 62.7 2,064 59.2 636 76.8 133 73.5 25 47.2 25 52.1
DOTS <0.0001
Yes 1,118 24.3 900 25.8 143 17.3 44 24.3 23 43.4 8 16.7
No 3,480 75.7 2,588 74.2 685 82.7 137 75.7 30 56.6 40 83.3
Community Health Worker Program <0.0001
Yes 303 6.6 279 8.0 15 1.8 3 1.7 6 11.3 0 0.0
No 4,295 93.4 3,209 92.0 813 98.2 178 98.3 47 88.7 48 100.0
DOTS: Directly Observed Treatment Short-Course
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DISCUSSION
DOTS coverage in the city of Rio de Janeiro City was 
24.3% in 2004. It was evidenced patient selection, 
despite recommendations for DOTS exclusive imple-
mentation in the context of high TB incidence, as well 
as to avoid patient selection biased by risk factors.5,10,22 
There was a high proportion of young patients in 
relapse or with a history of default or previous failure 
in the DOTS group. This may indicate that health care 
services tend to prioritize DOTS for potentially non-
compliant patients. A similar fi nding was reported in 
early DOTS implantation in the city of São José do Rio 
Preto, Southeastern Brazil.11
One of the primary health care with DOTS applied this 
strategy exclusively. This study found better health care 
indicators in DOTS than SAT patients. Although there 
were improvements associated with DOTS, the rates 
of unknown sputum smear and HIV status are high in a 
context where these tests are available. It may suggest 
low adherence to treatment guidelines affecting the 
course of treatment and disease.
The difference found between DOTS and SAT patients 
is not expressive, which is consistent with some studies 
of programs where DOTS is not exclusive.14,19 Better 
outcomes were identifi ed, however, when DOTS was 
provided together with the CHW Program, a strategy 
that allows for tailored case management.4,15 The 
strategy relying on CHW as enablers for keeping 
patients on treatment and thus achieving higher treat-
ment success rates should be considered as a way of 
organizing health care delivery and improving acces-
sibility – two major components of DOTS.
Default is a known major barrier to more effective 
treatment. In addition to the lack of incentives and 
enablers, diffi cult treatment access, poor communica-
tion between health providers and patients, poor appli-
cation of directly observed therapy, lack of an active 
search strategy for missing patients, and limitations of 
supervision in treatment units are all barriers to treat-
ment success in patients under DOTS.23
Higher rates of deaths among patients under DOTS 
were also reported in the city of São José do Rio 
Preto,11 and it probably refl ects the selection of patients 
with less favorable social and clinical conditions, not 
properly adjusted for in the model due to the lack of 
variables in the database. Additionally, the occur-
rence of deaths also varies depending on prior clinical 
history of patient, a fi nding that was also reported in 
a hyperendemic TB area in the state of São Paulo. 
7 Death was the outcome in 3.6%, 5.4%, 6.0%, and 
6.9% of those in initial treatment, with disease relapse, 
previous default, and previous failure, respectively, in 
the population studied.
With progressive implementation of DOTS in primary 
care units, TCP in Rio de Janeiro has improved TB care, 
but the goals were not achieved yet. The challenges is 
to evaluate and review DOTS implementation model 
taking into consideration context peculiarities as well 
as innovative strategies of health care organization and 
management.
The use of retrospective secondary data allowed to 
incorporating population data at the patient individual 
level and raised issues concerning cost-effective data 
quality control. TB treatment information fl ow is slow 
and frequently incomplete, especially concerning 
outcomes.1,17
DOTS was not implanted in all primary care units under 
TCP managed by Rio de Janeiro Health Department at 
the time of this study, which could have potentially intro-
duced a bias in the study. Health units with DOTS were 
located in almost all Rio de Janeiro Planning Areas (APs) 
with different TB incidence rates and sociodemographic 
profi les. However, we cannot assure that the subset of 
units with DOTS is a random sample of all units.
Data about the structure and health care processes 
in primary care units could affect treatment results 
obtained. The interviews with health care teams 
focused on the nine units with DOTS to characterize 
DOTS implementation. Hierarchical modeling factors 
at health care unit level that could provide more infor-
mation on factors at the patient level for explaining 
treatment outcome variation were not considered. Data 
collected concerning the units with DOTS showed 
relative homogeneity, probably because of DOTS 
implementation package.
In addition, differences between the number of patients 
reported in the study and those reported in the TB 
surveillance system of Rio de Janeiro City Health 
Department in the same period are due to the nature of 
the surveillance system and the focus of the study. This 
study focuses only on patients treated at primary health 
care units directly managed by the Health Department 
of Rio de Janeiro City. Many other federal and state 
health units report cases to the municipal surveillance 
system, but that treatment outcomes information have a 
delay of about one year to be included in the system.
It is important to increment DOTS coverage, empha-
sizing strategies that can enable health services to 
actively reach patients. In the city of Rio de Janeiro, 
there are special challenges regarding local condi-
tions, either related to health services or the popula-
tion’s living conditions and violent environment. 
It is necessary to implement other strategies for 
organizing, coordinating and managing health care, 
including continuous education for health providers 
based on clinical guidelines; direct supervision of 
health providers; establishment of goals and regular 
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